CoChat

The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.

Anti-Cholinesterase Combination Drug Therapy as a Potential Treatment for Alzheimer’s Disease

Open access

Abstract

Alzheimer’s disease (AD) is a burgeoning social and healthcare problem. Cholinesterase inhibitors (ChEIs) are employed for symptomatic treatment of AD, but often elicit adverse drug reactions (ADRs). Herein, the potency of the ChEIs, donepezil, tacrine, berberine, and galantamine to inhibit human or Torpedo californica acetylcholinesterase (tcAChE) proteins were evaluated. The efficacy of dual-drug combinations to inhibit human AChE directly and within differentiated neurons was also quantified. ChEI potency was in the order: donepezil > tacrine > berberine > galantamine for both AChEs. Dual-drug combinations of berberine and tacrine (BerTac), berberine and galantamine (BerGal), and tacrine and donepezil (TacDon) all produced synergistic outcomes for AChE inhibition. Donepezil and berberine (DonBer) and tacrine and galantamine (TacGal) elicited antagonistic responses. Donepezil and galantamine (DonGal) was synergistic for human AChE but antagonistic for tcAChE. After application of dual-drug combinations to neuronal cells, BerTac, BerGal, DonGal, and DonBer all showed synergistic inhibition of AChE, TacDon additive, and TacGal antagonistic effects. BerGal produced the most potent synergism and reduced total drug dose by 72%. Individual ChEIs or dual-drug combinations were relatively non-toxic to neuronal cells, and only reduced cell viability at concentrations two–three orders of magnitude greater than that required to inhibit AChE. In summary, dual-drug combinations of ChEIs potentially represent a novel means of AD patient treatment, with reduced and more cost-effective drug dosing, and lowered likelihood of ADRs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/brainsci11020184

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Structures of the cholinesterase inhibitor (ChEI) drugs.
Figure 1 Structures of the cholinesterase inhibitor (ChEI) drugs.CC BY · PubMed Central
Figure 2 Drug inhibition of acetylcholinesterase (AChE) protein in vitro: Human AChE (A) or Torpedo californica AChE (B) were incubated with donepezil (Don), tacrine (Tac), berberine (Ber), and galantamine (Gal) and the level of cholinesterase inhibition quantified. Dose-response effect curves were generated as fractional affect (Fa) 0.5 (representing the concentration producing 50% enzyme inhibition (IC50) against dose. Combination index (CI) plots for dual-drug inhibition of human AChE (C) and Torpedo californica AChE (D). BerTac = berberine and tacrine; BerGal = berberine and galantamine; TacDon = tacrine and donepezil; DonGal = donepezil and galantamine; DonBer = donepezil and berberine; TacGal = tacrine and galantamine.
Figure 2 Drug inhibition of acetylcholinesterase (AChE) protein in vitro: Human AChE (A) or Torpedo californica AChE (B) were incubated with donepezil (Don), tacrine (Tac), berberine (Ber), and galantamine (Gal) and the level of cholinesterase inhibition quantified. Dose-response effect curves were generated as fractional affect (Fa) 0.5 (representing the concentration producing 50% enzyme inhibition (IC50) against dose. Combination index (CI) plots for dual-drug inhibition of human AChE (C) and Torpedo californica AChE (D). BerTac = berberine and tacrine; BerGal = berberine and galantamine; TacDon = tacrine and donepezil; DonGal = donepezil and galantamine; DonBer = donepezil and berberine; TacGal = tacrine and galantamine.CC BY · PubMed Central
Figure 3 Drug inhibition of AChE within SH-SY5Y cells: Human neuroblastoma cells were incubated with donepezil (Don), tacrine (Tac), berberine (Ber), and galantamine (Gal) and the level of cholinesterase inhibition quantified (A). Combination index (CI) plot of dual-drug inhibition of AChE (B). BerTac = berberine and tacrine; BerGal = berberine and galantamine; TacDon = tacrine and donepezil; DonGal = donepezil and galantamine; DonBer = donepezil and berberine; TacGal = tacrine and galantamine.
Figure 3 Drug inhibition of AChE within SH-SY5Y cells: Human neuroblastoma cells were incubated with donepezil (Don), tacrine (Tac), berberine (Ber), and galantamine (Gal) and the level of cholinesterase inhibition quantified (A). Combination index (CI) plot of dual-drug inhibition of AChE (B). BerTac = berberine and tacrine; BerGal = berberine and galantamine; TacDon = tacrine and donepezil; DonGal = donepezil and galantamine; DonBer = donepezil and berberine; TacGal = tacrine and galantamine.CC BY · PubMed Central
Figure 4 Virtual ChEI dual-drug combination pills: A virtual berberine and galantamine (BerGal) pill would have a 72% reduction of total drug dose (A). A virtual berberine and tacrine (BerTac) pill would have a 66% reduction of total drug dose (B).
Figure 4 Virtual ChEI dual-drug combination pills: A virtual berberine and galantamine (BerGal) pill would have a 72% reduction of total drug dose (A). A virtual berberine and tacrine (BerTac) pill would have a 66% reduction of total drug dose (B).CC BY · PubMed Central
Figure 5 Cytotoxicity of individual and dual-drug ChEI combinations to SH-SY5Y cells: Human neuroblastoma cells were incubated with donepezil (Don), tacrine (Tac), berberine (Ber), and galantamine (Gal) or dual-drug combinations: BerTac (berberine and tacrine), BerGal (berberine and galantamine), TacDon (tacrine and donepezil), DonGal (donepezil and galantamine), DonBer (donepezil and berberine), and TacGal (tacrine and galantamine), and cell viability quantified using a MTT assay. Significant changes were quantified using a one-way ANOVA. ns = non-significant effect on cell viability. All other histograms not marked with ns, displayed significant changes from controls.
Figure 5 Cytotoxicity of individual and dual-drug ChEI combinations to SH-SY5Y cells: Human neuroblastoma cells were incubated with donepezil (Don), tacrine (Tac), berberine (Ber), and galantamine (Gal) or dual-drug combinations: BerTac (berberine and tacrine), BerGal (berberine and galantamine), TacDon (tacrine and donepezil), DonGal (donepezil and galantamine), DonBer (donepezil and berberine), and TacGal (tacrine and galantamine), and cell viability quantified using a MTT assay. Significant changes were quantified using a one-way ANOVA. ns = non-significant effect on cell viability. All other histograms not marked with ns, displayed significant changes from controls.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Cited by

See all 43

Metadata

Authors
Amat-ur-Rasool, H., Ahmed, M., Hasnain, S., & Carter, W. G.
Affiliations
  • University of Nottingham (GB)
  • University of the Punjab (PK)
Corresponding author
Carter, Wayne G.
Venue
Brain Sciences
Publisher
MDPI AG
Published
2021-02-02
Volume
11
Issue
2
Pages
184
ISSN
2076-3425 (ISSN-L)
OpenAlex
W3128108545
Cited by
43
References
51
Citations by year
2026: 10 · 2025: 8 · 2024: 6 · 2023: 6 · 2022: 9 · 2021: 4
FWCI
3.65
Type
journal article
Language
en
Open access
Locations
  • Brain Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Repository@Nottingham (University of Nottingham) (publishedVersion, cc-by)
  • Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Higher Education Commision, Pakistan (315-78152BS3-096, IRSIP No.1-8 /HEC/ HRD/2018/8570), NRPU Grant 8288)
  • Commonwealth Scholarship Commission (PKCN-2018-267)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pesticide Exposure and Toxicity
Keywords
Alzheimer's disease, cholinesterase inhibitors, combination therapy, acetylcholinesterase inhibition, donepezil, tacrine, berberine, galantamine, synergistic effect, antagonism, adverse drug reactions, neurons, Torpedo californica acetylcholinesterase, drug toxicity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti-Cholinesterase Combination Drug Therapy as a Potential Treatment for Alzheimer’s Disease. https://app.cochat.ai/papers/10.3390/brainsci11020184
The paper
Amat-ur-Rasool, H., Ahmed, M., Hasnain, S., & Carter, W. G. (2021). Anti-Cholinesterase Combination Drug Therapy as a Potential Treatment for Alzheimer’s Disease. Brain Sciences. https://doi.org/10.3390/brainsci11020184

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.